Royalty Pharma
RPRX
#621
Rank
โ‚น3.683 T
Marketcap
โ‚น6,406
Share price
-0.01%
Change (1 day)
83.33%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2026 (TTM): โ‚น143.81 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are โ‚น2.61 Billion. In 2025 the company made an earning of โ‚น152.14 Billion, an increase over its 2024 earnings that were of โ‚น145.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น143.81 B-5.47%
2025 โ‚น152.14 B4.79%
2024 โ‚น145.18 B-17.54%
2023 โ‚น176.06 B351.47%
2022 โ‚น38.99 B-70.3%
2021 โ‚น131.29 B-24.3%
2020 โ‚น173.42 B-31.9%
2019 โ‚น254.68 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
โ‚น673.36 B 367.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.243 T 2,151.45%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น14.72 B-89.78%๐Ÿ‡บ๐Ÿ‡ธ USA